4//SEC Filing
ARGOS THERAPEUTICS INC 4
Accession 0001543053-16-000003
CIK 0001105533operating
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:35 PM ET
Size
5.4 KB
Accession
0001543053-16-000003
Insider Transaction Report
Form 4
Harrelson Lori R.
Vice President of Finance
Transactions
- Award
Stock Option (right to buy)
2016-06-13+40,000→ 40,000 totalExercise: $7.41Exp: 2026-06-12→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 13, 2016 and vests as to 25% of the shares underlying this option on June 13, 2017, with the remaining 75% of the shares underlying this option vesting in equal amounts monthly over the next three years beginning June 13, 2017.
Documents
Issuer
ARGOS THERAPEUTICS INC
CIK 0001105533
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001105533
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:35 PM ET
- Size
- 5.4 KB